Qiagen NV Company Leadership
QGEN Stock | USD 44.51 0.74 1.69% |
Qiagen NV employs about 5.8 K people. The company is managed by 20 executives with a total tenure of roughly 109 years, averaging almost 5.0 years of service per executive, having 290.0 employees per reported executive. Analysis of Qiagen NV's management performance can provide insight into the firm performance.
Thierry Bernard CEO Chief Executive Officer, Managing Director, Member of the Executive Board |
Metin Colpan Chairman Co-Founder, Supervisory Director and Chairman of Science and Technology Committee |
Qiagen |
Qiagen NV's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Qiagen NV's future performance. Based on our forecasts, it is anticipated that Qiagen will maintain a workforce of about 5800 employees by March 2025.Qiagen NV Management Team Effectiveness
The company has return on total asset (ROA) of 0.0484 % which means that it generated a profit of $0.0484 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0257 %, meaning that it created $0.0257 on every $100 dollars invested by stockholders. Qiagen NV's management efficiency ratios could be used to measure how well Qiagen NV manages its routine affairs as well as how well it operates its assets and liabilities. As of the 31st of January 2025, Return On Capital Employed is likely to grow to 0.11, while Return On Tangible Assets are likely to drop 0.09. At this time, Qiagen NV's Fixed Asset Turnover is very stable compared to the past year. As of the 31st of January 2025, Asset Turnover is likely to grow to 0.56, while Intangible Assets are likely to drop about 465.5 M.As of the 31st of January 2025, Net Income Applicable To Common Shares is likely to grow to about 695.1 M, while Common Stock Shares Outstanding is likely to drop about 202.8 M.
Qiagen NV Workforce Comparison
Qiagen NV is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 185,581. Qiagen NV holds roughly 5,800 in number of employees claiming about 3% of equities under Health Care industry.
Qiagen NV Profit Margins
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.75 | 0.72 |
|
| |||||
Operating Profit Margin | 0.14 | 0.2 |
|
|
Qiagen NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Qiagen NV Price Series Summation is a cross summation of Qiagen NV price series and its benchmark/peer.
Qiagen NV Notable Stakeholders
A Qiagen NV stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Qiagen NV often face trade-offs trying to please all of them. Qiagen NV's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Qiagen NV's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thierry Bernard | Chief Executive Officer, Managing Director, Member of the Executive Board | Profile | |
Metin Colpan | Co-Founder, Supervisory Director and Chairman of Science and Technology Committee | Profile | |
Lawrence Rosen | Independent Chairman of the Supervisory Board | Profile | |
Jonathan Sheldon | Senior Vice President Member of the Executive Committee | Profile | |
Thomas Schweins | Senior Vice President - Human Resources, Strategy & Marketing Services | Profile | |
John Gilardi | VP of Corporate Communications and Investor Relations | Profile | |
Roland Sackers | Managing Director, Chief Financial Officer, Member of the Executive Committee | Profile | |
Stephane Bancel | Independent Member of the Supervisory Board | Profile | |
Fernando Beils | Senior Area | Profile | |
JeanPascal Viola | Senior Development | Profile | |
Elaine Mardis | Independent Member of the Supervisory Board | Profile | |
Thomas Ebeling | Independent Member of the Supervisory Board | Profile | |
Elizabeth Tallett | Independent Member of the Supervisory Board | Profile | |
Stephany Foster | Senior Resources | Profile | |
Thomas Neidert | Vice Treasury | Profile | |
Thomas Theuringer | Director Communications | Profile | |
Antonio Santos | Senior Operations | Profile | |
Toralf Haag | Independent Member of the Supervisory Board | Profile | |
Ross Levine | Independent Member of the Supervisory Board | Profile | |
Dominic John | Vice Management | Profile |
About Qiagen NV Management Performance
The success or failure of an entity such as Qiagen NV often depends on how effective the management is. Qiagen NV management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Qiagen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Qiagen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.13 | 0.09 | |
Return On Capital Employed | 0.10 | 0.11 | |
Return On Assets | 0.06 | 0.06 | |
Return On Equity | 0.10 | 0.10 |
Qiagen NV Workforce Analysis
Traditionally, organizations such as Qiagen NV use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Qiagen NV within its industry.Qiagen NV Manpower Efficiency
Return on Qiagen NV Manpower
Revenue Per Employee | 338.8K | |
Revenue Per Executive | 98.3M | |
Net Income Per Employee | 58.8K | |
Net Income Per Executive | 17.1M | |
Working Capital Per Employee | 184.2K | |
Working Capital Per Executive | 53.4M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.46 | Revenue Per Share | Quarterly Revenue Growth 0.055 | Return On Assets |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.